Ginsenoside Re reduces insulin resistance through inhibition of c-Jun NH2-terminal kinase and nuclear factor-κB

Molecular Endocrinology

Volumn 22, Issue 1, 2008, Pages 186-195

  Zhang, Zhiguo ^a,b   Li, Xiaoying ^a,b   Lv, Wenshan ^b   Yang, Yisheng ^b   Gao, Hong ^b   Yang, Jun ^b   Shen, Yun ^a   Ning, Guang ^a,b  

^a Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GINSENOSIDE; GLUCOSE; GLUCOSE TRANSPORTER 4; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR BETA; INSULIN RECEPTOR SUBSTRATE 1; ISOPHANE INSULIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DEGRADATION KINETICS; DIABETES MELLITUS; DOWNSTREAM PROCESSING; ENZYME INHIBITION; GLUCOSE CLAMP TECHNIQUE; GLUCOSE INFUSION; GLUCOSE TRANSPORT; HYPERGLYCEMIA; INHIBITION KINETICS; INSULIN RESISTANCE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; 3T3-L1 CELLS; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BIOLOGICAL TRANSPORT; BLOTTING, WESTERN; DIETARY FATS; GINSENOSIDES; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; HYPERGLYCEMIA; IMMUNOPRECIPITATION; INSULIN RESISTANCE; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MICE; NF-KAPPA B; PHOSPHORYLATION; RATS; RATS, WISTAR; TYROSINE;

PANAX GINSENG; RATTUS;

EID: 38049063954     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2007-0119     Document Type: Article

References (39)

1. Saltiel AR 2001 New perspectives into the molecular pathogenesis and treatment of type 2 diabetes. Cell 104:517-529
2. Li WL, Zheng HC, Bukuru J, De Kimpe N 2004 Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus. J Ethnopharmacol 92:1-21
3. World Health Organization 1999 WHO monographs on selected medicinal plants. Geneva: World Health Organization; 168-183
4. Han KL, Jung MH, Sohn JH, Hwang JK 2006 Ginsenoside 20(S)- protopanaxatriol (PPT) activates peroxisome proliferator-activated receptor γ (PPARγ) in 3T3-L1 adipocytes. Biol Pharm Bull 29:110-113
5. Dey L, Xie JT, Wang A, Wu J, Maleckar SA, Yuan CS 2003 Antihyperglycemic effects of ginseng: comparison between root and berry. Phytomedicine 10:600-605
6. Sotaniemi EA, Haapakoski E, Rautio A 1995 Ginseng therapy in noninsulin-dependent diabetic patients. Diabetes Care 18:1373-1375
7. Yeh GY, Eisenberg DM, Kaptchuk TJ, Phillips RS 2003 Systematic review of herbs and dietary supplements for glycemic control in diabetes. Diabetes Care 26:1277-1294
8. Attele AS, Zhou YP, Xie JT, Wu JA, Zhang L, Dey L, Pugh, W, Rue PA, Polonsky KS, Yuan CS 2002 Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. Diabetes 51:1851-1858
9. Xie JT, Mehendale SR, Li X, Quigg R, Wang X, Wang CZ, Wu JA, Aung HH, A Rue P, Bell GI, Yuan CS 2005 Anti-diabetic effect of ginsenoside Re in ob/ob mice. Biochim Biophys Acta 1740:319-325
10. Cho WC, Chung WS, Lee SK, Leung AW, Cheng CH, Yue KK 2006 Ginsenoside Re of Panax ginseng possesses significant antioxidant and antihyperlipidemic efficacies in streptozotocin-induced diabetic rats. Eur J Pharmacol 550:173-179
11. Cho WC, Yip TT, Chung WS, Lee SK, Leung AW, Cheng CH, Yue KK 2006 Altered expression of serum protein in ginsenoside Re-treated diabetic rats detected by SELDITOF MS. J Ethnopharmacol 108:272-279
12. Watson RT, Kanzaki M, Pessin JE 2004 Regulated membrane trafficking of the insulin-responsive glucose transporter 4 in adipocytes. Endocr Rev 25:177-204
13. Shoelson SE, Lee J, Goldfine AB 2006 Inflammation and insulin resistance. J Clin Invest 116:1793-1801
14. Hotamisligil GS 2006 Inflammation and metabolic disorders. Nature 444:860-867
15. 2-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser307. J Biol Chem 275:9047-9054
16. Aguirre V, Werner ED, Giraud J, Lee YH, Shoelson SE, White MF 2002 Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action J Biol Chem 277:1531-1537
17. Perrini S, Natalicchio A, Laviola L, Belsanti G, Montrone C, Cignarelli A, Minielli V, Grano M, De Pergola G, Giorgino R, Giorgino F 2004 Dehydroepiandrosterone stimulates glucose uptake in human and murine adipocytes by inducing GLUT1 and GLUT4 translocation to the plasma membrane. Diabetes 53:41-52
18. Attele AS, Wu JA, Yuan CS 1999 Ginseng pharmacology: multiple constituents and multiple actions. Biochem Pharmacol 58:1685-1693
19. Lewis C. Cantley 2002 The phosphoinositide 3-kinase pathway. Science 296:1655-1657
20. Sano H, Kane S, Sano E, Miinea CP, Asara JM, Lane WS, Garner CW, Lienhard GE 2003 Insulin-stimulated phosphorylation of a Rab GTPase-activating protein regulates GLUT4 translocation. J Biol Chem 278:14599-14602
21. Zeigerer A, McBrayer MK, McGraw TE 2004 Insulin stimulation of GLUT4 exocytosis, but not its inhibition of endocytosis, is dependent on RabGAP AS160. Mol Biol Cell 15:4406-4415
22. Wellen KE, Hotamisligil GS 2005 Inflammation, stress, and diabetes J Clin Invest 115:1111-1119
23. Barzilay JI, Freedland ES 2003 Inflammation and its relationship to insulin resistance, type 2 diabetes mellitus, and endothelial dysfunction. Metab Syndrome 1:55-67
24. Festa A, D'Agostino Jr R, Tracy RP, Haffner SM 2002 Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes 51:1131-1137
25. Hotamisligil GS, Shargill NS, Spiegelman BM 1993 Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 259:87-91
26. Feinstein R, Kanety H, Papa MZ, Lunenfeld B, Karasik A 1993 Tumor necrosis factor-α suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. J Biol Chem 268:26055-26058
27. Hotamisligil GS, Spiegelman BM 1994 Tumor necrosis factor α: a key component of the obesity-diabetes link. Diabetes 143:1271-1278
28. Paz K, Hemi R, LeRoith D, Karasik A, Elhanany E, Kanety H, Zick YA 1997 Molecular basis for insulin resistance: elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation. J Biol Chem 272:29911-29918
29. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM 1996 IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α- and obesity-induced insulin resistance. Science 271:665-668
30. Zick Y 2005 Ser/Thr phosphorylation of IRS proteins: a molecular basis for insulin resistance. Sci STKE 268:pe4
31. Hirosumi J, Tuncman G, Chang L, Gorgun CZ, Uysal KT, Maeda K, Karin M, Hotamisligil GS 2002 A central role for JNK in obesity and insulin resistance. Nature 420:333-336
32. Bennett BL, Satoh Y, Lewis AJ 2003 JNK: a new therapeutic target for diabetes. Curr Opin Pharmacol 3:420-425
33. Qi C, Pekala PH 2000 Tumour necrosis factor-α-induced insulin resistance in adipocytes. Proc Soc Exp Biol Med 223:128-135
34. Gao Z, Zuberi A, Quon MJ, Dong Z, Ye J 2003 Aspirin inhibits serine phosphorylation of insulin receptor substrate 1 in tumor necrosis factor-treated cells through targeting multiple serine kinases. J Biol Chem 278:24944-24950
35. Kanatani Y, Usui I, Ishizuka K, Bukhari A, Fujisaka S, Urakaze M, Haruta T, Kishimoto T, Naka T, Kobayashi M 2007 Effects of pioglitazone on suppressor of cytokine signaling 3 expression. Diabetes 56:795-803
36. Seo JY, Lee JH, Kim NW, Kim YJ, Chang SH, Ko NY, Her E, Yoo YH, Kim JW, Lee BY, Lee HY, Kim YM, Choi WS 2005 Inhibitory effects of a fermented ginseng extract, BST204, on the expression of inducible nitric oxide synthase and nitric oxide production in lipopolysaccharide-activated murine macrophages. J Pharm Pharmacol 57:911-918
37. Keum YS, Han SS, Chun KS, Park KK, Park JH, Lee SK, Surh YJ 2003 Inhibitory effects of the ginsenoside Rg3 on phorbol ester-induced cyclooxygenase-2 expression, NF-κB activation and tumor promotion. Mutat Res 523-524:75-85
38. Shisheva A, Buxton J, Czech MP 1994 Differential intracellular localizations of GDP dissociation inhibitor isoforms. J Biol Chem 269:23865-23868
39. Cleasby ME, Dzamko N, Hegarty BD, Cooney GJ, Kraegen EW, Ye JM 2004 Metformin prevents the development of acute lipid-induced insulin resistance in the rat through altered hepatic signaling mechanisms. Diabetes 53:3258-3266